Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.
Advertisement
You can also search for this author in PubMed Google Scholar
In a controversial move, Australia will become the world’s first country to allow the drugs psilocybin and MDMA to be prescribed by doctors to treat psychiatric conditions including depression and post-traumatic stress disorder. But many scientists are concerned that research has not yet conclusively shown that these drugs are safe or effective. And some clinicians fear that the regulation that will govern access to the drugs is insufficient.
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Nature 619, 227-228 (2023)
doi: https://doi.org/10.1038/d41586-023-02093-8
Hadar, A. et al. J. Psychoactive Drugs https://doi.org/10.1080/02791072.2021.2022254 (2022).
Article PubMed Google Scholar
Goodwin, G. M. et al. N. Engl. J. Med. 87, 1637–1648 (2022).
Article Google Scholar
Mitchell, J. M. et al. Nature Med. 27, 1025–1033 (2021).
Article PubMed Google Scholar
Rossell, S. L., Meikle, S. E., Williams, M. L. & Castle, D. J. Aust. NZ J. Psychiatry 57, 935–936 (2023).
Article Google Scholar
Download references
Reprints and permissions
How ecstasy and psilocybin are shaking up psychiatry
How psychedelic drugs achieve their potent health benefits
US could soon approve MDMA therapy — opening an era of psychedelic medicine
Psychedelic drugs without the trip? This sensor could help seek them out
Virtual library of LSD-like drugs could reveal new antidepressants
Psychedelic compound in ecstasy moves closer to approval to treat PTSD
MDMA therapy for PTSD rejected by FDA panel
News
Internet use and teen mental health: it’s about more than just screen time
Correspondence
Social-media influence on teen mental health goes beyond just cause and effect
Correspondence
MDMA therapy for PTSD rejected by FDA panel
News
Autistic people three times more likely to develop Parkinson’s-like symptoms
News
Neural pathways for reward and relief promote fentanyl addiction
News & Views
Hybrid working has benefits over fully in-person working — the evidence mounts
Editorial
Why role-playing games can spur climate action
World View
How does ChatGPT ‘think’? Psychology and neuroscience crack open AI large language models
News Feature
Investigations on Alzheimer's disease pathology and the search for novel therapeutic strategies.
Montréal, Quebec (CA)
Prof. A. Claudio Cuello
Postdoctoral positions funded by NIH are for study of meiosis and spermatogonial stem cells using mouse models. Generous stipend and benefits.
Philadelphia, Pennsylvania (US)
University of Pennsylvania – Department of Biomedical Sciences
Associate or Senior Editor (Materials Science) Organization: Nature Communications Location(s): New York, Jersey City, Philadelphia, Beijing, Hong …
New York (US)
Springer Nature Ltd
Associate or Senior, Nature Medicine: Infectious Diseases New York, Shanghai or Beijing – Hybrid Working Application Deadline: August 1, 2024 Nat…
New York City, New York (US)
Springer Nature Ltd
Funded investigator has an immediate opening for a post-doctoral fellow to develop therapies for genetic diseases.
Johns Hopkins School of Medicine, East Baltimore Campus
Johns Hopkins University Department of Medicine
How ecstasy and psilocybin are shaking up psychiatry
How psychedelic drugs achieve their potent health benefits
US could soon approve MDMA therapy — opening an era of psychedelic medicine
Psychedelic drugs without the trip? This sensor could help seek them out
Virtual library of LSD-like drugs could reveal new antidepressants
Psychedelic compound in ecstasy moves closer to approval to treat PTSD
An essential round-up of science news, opinion and analysis, delivered to your inbox every weekday.
Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.
© 2024 Springer Nature Limited